TREA

Cold temperature-resistant microbials and methods of their use

Follow

Information

  • Patent Grant
  • 12157690
  • Patent Number
    12,157,690
  • Date Filed
    Friday, December 9, 2016
    8 years ago
  • Date Issued
    Tuesday, December 3, 2024
    2 months ago
Information
Abstract
The invention relates to cold temperature-resistant microbials for use in waste water treatment. More particularly, the invention relates to isolated Bacillus strains ALG and DRT, and strains having all of the identifying characteristics of these strains, and combinations thereof, for a use comprising the above-mentioned use.
Description
FIELD OF THE DISCLOSURE

The invention relates to cold temperature-resistant microbial strains for use in wastewater treatment. More particularly, the invention relates to isolated Bacillus strains ALG and DRT, and strains having all of the identifying characteristics of these strains, and combinations thereof, for a use comprising the above-mentioned use.


BACKGROUND AND SUMMARY OF THE INVENTION

The present invention relates to cold temperature-resistant microorganisms for use in wastewater treatment (e.g., industrial wastewater and sewage), and methods of their use for treatment of wastewater. The ability of microbial strains, such as Bacillus strains, to produce beneficial enzymes, and their antimicrobial activity and environmental compatibility, have led to the use of these microbial strains in wastewater treatment. For example, beneficial microbial strains can be used to reestablish the balance of bacteria beneficial to the environment, degrade harmful organic compounds in wastewater, or remove pollutants, such as inorganic pollutants (e.g., nitrogen or sulfur) from wastewater.


Microbial strains effective for use in wastewater treatment should be active at a variety of temperatures, in particular cold temperatures. For example, as little as a ten degree drop in temperature can bring about as much as a 50% loss in microbial activity. To maintain microbial strain activity for wastewater treatment during colder periods, it is important to use cold temperature-resistant microorganisms that will be active at lower temperatures. Many commercial microbial strains, or strain combinations, do not work well at low temperatures (e.g., 4° C.-10° C.). Thus, microbial strains, or strain combinations, are needed that are active even at the low temperatures often encountered during the wastewater treatment process.


Applicants have developed Bacillus strains, and combinations thereof, that remain active at low temperatures. In one embodiment a method of treating wastewater to remove a pollutant is provided. The method comprises contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the pollutant.


In another embodiment, a method of controlling a detrimental effect of wastewater is provided. The method comprises contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and controlling the detrimental effect of the wastewater.


In various other embodiments, a commercial package, an additive for wastewater, and a composition are provided. The commercial package, additive for wastewater, and composition comprise an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


The following clauses, and combinations thereof, provide various additional illustrative aspects of the invention described herein. The various embodiments described in any other section of this patent application, including the section titled “DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS” and the EXAMPLES are applicable to any of the following embodiments of the invention described in the numbered clauses below.


1. A method of treating wastewater to remove a pollutant, the method comprising contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the pollutant.


2. The method of clause 1 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.


3. The method of clause 1 or 2 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, municipal wastewater, wastewater from the manufacture of oil or gas, plant wastewater, and wastewater from the manufacture of food.


4. The method of any one of clauses 1 to 3 wherein the pollutant is selected from the group consisting of a harmful microorganism, an organic compound, an inorganic compound, and combinations thereof.


5. The method of clause 4 wherein the pollutant is a harmful microorganism and the microorganism is killed.


6. The method of any one of clauses 1 to 5 wherein at least one of the Bacillus strains has antimicrobial activity.


7. The method of clause 6 wherein the antimicrobial activity is against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof.


8. The method of clause 4 wherein the pollutant is an organic compound.


9. The method of clause 8 wherein the organic compound is removed by degradation.


10. The method of clause 8 wherein the organic compound is selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste.


11. The method of clause 4 wherein the pollutant is an inorganic compound.


12. The method of clause 11 wherein the inorganic compound is nitrogen or sulfur.


13. The method of any one of clauses 1 to 12 wherein the Bacillus strain produces an enzyme selected from the group consisting of an a protease, an amylase, a xylanase, a cellulase, and combinations thereof.


14. The method of clause 13 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.


15. The method of any one of clauses 1 to 14 further comprising treating the wastewater with another bacterial strain selected from the group consisting of another Bacillus strain, a lactic acid bacterial strain, and combinations thereof.


16. The method of any one of clauses 1 to 15 wherein the strain is Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134).


17. The method of any one of clauses 1 to 15 wherein the strain is Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135).


18. The method of any one of clauses 1 to 15 wherein the wastewater is treated with a composition comprising Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in a single composition.


19. The method of any one of clauses 1 to 15 wherein the wastewater is treated with Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in separate compositions.


20. The method of any one of clauses 1 to 19 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 5.0×1012 CFU/liter of the wastewater.


21. The method of any one of clauses 1 to 19 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 1.0×1010 CFU/liter of the wastewater.


22. The method of any one of clauses 1 to 19 wherein the effective amount is an amount greater than about 1.0×103 CFU/liter of the wastewater.


23. The method of any one of clauses 1 to 22 further comprising contacting the wastewater with an enzyme selected from the group consisting of a galactosidase, a protease, a lipase, an amylase, a hemicellulase, an arabinoxylanase, a xylanase, a cellulase, an NSPase, a phytase, and combinations thereof.


24. A method of controlling a detrimental effect of wastewater, the method comprising contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and controlling the detrimental effect of the wastewater.


25. The method of clause 24 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.


26. The method of clause 24 or 25 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, wastewater from the manufacture of oil or gas, plant wastewater, municipal wastewater, and wastewater from the manufacture of food.


27. The method of any one of clauses 24 to 26 wherein the detrimental effect of the wastewater is caused by a pollutant selected from the group consisting of a harmful microorganism, an organic compound, an inorganic compound, and combinations thereof.


28. The method of clause 27 wherein the pollutant is a harmful microorganism and the microorganism is killed.


29. The method of any one of clauses 24 to 28 wherein at least one of the Bacillus strains has antimicrobial activity.


30. The method of clause 29 wherein the antimicrobial activity is against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof.


31. The method of clause 27 wherein the pollutant is an organic compound.


32. The method of clause 31 wherein the organic compound is removed by degradation.


33. The method of clause 31 wherein the organic compound is selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste.


34. The method of clause 27 wherein the pollutant is an inorganic compound.


35. The method of clause 35 wherein the inorganic compound is nitrogen or sulfur.


36. The method of any one of clauses 24 to 35 wherein the Bacillus strain produces an enzyme selected from the group consisting of an a protease, an amylase, a xylanase, a cellulase, and combinations thereof.


37. The method of clause 36 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.


38. The method of any one of clauses 24 to 37 further comprising contacting the wastewater with another bacterial strain selected from the group consisting of another Bacillus strain, a lactic acid bacterial strain, and combinations thereof.


39. The method of any one of clauses 24 to 38 wherein the strain is Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134).


40. The method of any one of clauses 24 to 38 wherein the strain is Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135).


41. The method of any one of clauses 24 to 38 wherein the wastewater is contacted with a composition comprising Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in a single composition.


42. The method of any one of clauses 24 to 38 wherein the wastewater is contacted with Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in separate compositions.


43. The method of any one of clauses 24 to 42 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 5.0×1012 CFU/liter of the wastewater.


44. The method of any one of clauses 24 to 42 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 1.0×1010 CFU/liter of the wastewater.


45. The method of any one of clauses 24 to 42 wherein the effective amount is an amount greater than about 1.0×103 CFU/liter of the wastewater.


46. The method of any one of clauses 24 to 45 further comprising contacting the wastewater with an enzyme selected from the group consisting of a galactosidase, a protease, a lipase, an amylase, a hemicellulase, an arabinoxylanase, a xylanase, a cellulase, an NSPase, a phytase, and combinations thereof.


47. A commercial package comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


48. An additive for wastewater comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


49. A composition comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


50. The commercial package, additive, or composition of any one of clauses 47 to 49 wherein the Bacillus strain causes degradation of an organic compound or removal of an inorganic compound in wastewater.


51. The commercial package, additive, or composition of any one of clauses 47 to 50 wherein the Bacillus strain inhibits a pathogen selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Campylobacter, and Clostridium.


52. The commercial package, additive, or composition of any one of clauses 47 to 51 wherein the Bacillus strain is in the form of a concentrate.


53. The commercial package, additive, or composition of any one of clauses 47 to 51 wherein the Bacillus strain is in the form of a superconcentrate.


54. The commercial package, additive, or composition of any one of clauses 47 to 53 wherein the Bacillus strain is in dry form.


55. The commercial package, additive, or composition of any one of clauses 47 to 54 wherein the Bacillus strain is in pelleted form.


56. The commercial package, additive, or composition of any one of clauses 47 to 55 wherein the Bacillus strain is in a form for use in treatment of wastewater selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, municipal wastewater, wastewater from the manufacture of oil or gas, plant wastewater, and wastewater from the manufacture of food.


57. The commercial package, additive, or composition of any one of clauses 47 to 56 wherein the strain is in a form selected from the group consisting of a powder, a liquid, and a pellet form.


58. The commercial package, additive, or composition of any one of clauses 47 to 57 further comprising a carrier for the Bacillus strain.


59. The commercial package, additive, or composition of clause 58 wherein the carrier is selected from the group consisting of salt, a dextrin, and combinations thereof.


60. The commercial package, additive, or composition of any one of clauses 47 to 59 in a bag.


61. The commercial package, additive, or composition of clause 60 wherein the bag is a plastic bag.


62. The commercial package, additive, or composition of any one of clauses 47 to 61 further comprising instructions for use of one or more of the Bacillus strains.


63. The commercial package, additive, or composition of any one of clauses 47 to 62 in a 20-pound bag.


64. The commercial package, additive, or composition of any one of clauses 47 to 62 in a 50-pound bag.


65. The commercial package, additive, or composition of any one of clauses 47 to 54 or 56 to 64 wherein the Bacillus strain is in powder form.


66. The commercial package, additive, or composition of any one of clauses 47 to 53 or 56 to 62 wherein the Bacillus strain is in liquid form.


67. The commercial package, additive, or composition of any one of clauses 47 to 66 wherein the Bacillus strain is in a container for commercial use.


68. The commercial package, additive, or composition of clause 67 wherein the container comprises plastic.


69. The commercial package, additive, or composition of clause 67 wherein the container comprises paper.


70. The commercial package, additive, or composition of any one of clauses 47 to 69 further comprising a binder.


71. The commercial package, additive, or composition of clause 70 wherein the binder is selected from the group consisting of clay, yeast cell wall components, aluminum silicate, and glucan, or combinations thereof.


72. The method, commercial package, additive, or composition of any one of clauses 1 to 71 wherein the Bacillus strain retains activity at a temperature as low as 4° C.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a graph showing the biological activities (growth) of ALG and DRT microbial composites independently, a combination of ALG and DRT microbial composites, and a control sample in treated industrial wastewater at 4° C. over time.



FIG. 1B is a graph showing the biological activities (growth) of ALG and DRT microbial composites independently, a combination of ALG and DRT microbial composites, and a control sample in treated industrial wastewater at 20° C. over time.



FIG. 1C is a graph showing the biological activities (growth) of ALG and DRT microbial composites independently, a combination of ALG and DRT microbial composites, and a control sample in treated dairy pond industrial wastewater at 4° C. over time.



FIG. 1D is a graph showing the biological activities (growth) of ALG and DRT microbial composites independently, a combination of ALG and DRT microbial composites, and a control sample in treated dairy pond industrial wastewater at 4° C. over time.



FIG. 2 is a genomic map showing genomic annotation of microbial strain ALG.



FIG. 3 is a genomic map showing genomic annotation of microbial strain DRT.





For FIGS. 1A-D, the top line is the combination, the bottom line is the control, and ALG is the top line of the intermediate two lines, except for FIG. 1A in which the intermediate lines are the reverse (i.e., DRT is the top line of the two intermediate lines).


DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

Applicants have developed Bacillus strains, and combinations thereof, that remain active at low temperatures. The Bacillus strains are used in wastewater treatment. More particularly, isolated Bacillus strains ALG and DRT, and strains having all of the identifying characteristics of these strains, or combinations thereof, can be used for wastewater treatment.


In one embodiment a method of treating wastewater to remove a pollutant is provided. The method comprises contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the pollutant.


In another embodiment, a method of controlling a detrimental effect of wastewater is provided. The method comprises contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and controlling the detrimental effect of the wastewater.


In various other embodiments, a commercial package, an additive for wastewater, and a composition are provided. The commercial package, additive for wastewater, and composition comprise an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


The following clauses, and combinations thereof, provide various additional illustrative aspects of the invention described herein. The various embodiments described in this section titled “DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS” are applicable to any of the following embodiments of the invention described in the numbered clauses below.


1. A method of treating wastewater to remove a pollutant, the method comprising contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the pollutant.


2. The method of clause 1 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.


3. The method of clause 1 or 2 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, wastewater from the manufacture of oil or gas, plant wastewater, and wastewater from the manufacture of food.


4. The method of any one of clauses 1 to 3 wherein the pollutant is selected from the group consisting of a harmful microorganism, an organic compound, an inorganic compound, and combinations thereof.


5. The method of clause 4 wherein the pollutant is a harmful microorganism and the microorganism is killed.


6. The method of any one of clauses 1 to 5 wherein at least one of the Bacillus strains has antimicrobial activity.


7. The method of clause 6 wherein the antimicrobial activity is against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof.


8. The method of clause 4 wherein the pollutant is an organic compound.


9. The method of clause 8 wherein the organic compound is removed by degradation.


10. The method of clause 8 wherein the organic compound is selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste.


11. The method of clause 4 wherein the pollutant is an inorganic compound.


12. The method of clause 11 wherein the inorganic compound is nitrogen or sulfur.


13. The method of any one of clauses 1 to 12 wherein the Bacillus strain produces an enzyme selected from the group consisting of an a protease, an amylase, a xylanase, a cellulase, and combinations thereof.


14. The method of clause 13 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.


15. The method of any one of clauses 1 to 14 further comprising treating the wastewater with another bacterial strain selected from the group consisting of another Bacillus strain, a lactic acid bacterial strain, and combinations thereof.


16. The method of any one of clauses 1 to 15 wherein the strain is Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134).


17. The method of any one of clauses 1 to 15 wherein the strain is Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135).


18. The method of any one of clauses 1 to 15 wherein the wastewater is treated with a composition comprising Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in a single composition.


19. The method of any one of clauses 1 to 15 wherein the wastewater is treated with Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in separate compositions.


20. The method of any one of clauses 1 to 19 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 5.0×1012 CFU/liter of the wastewater.


21. The method of any one of clauses 1 to 19 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 1.0×1010 CFU/liter of the wastewater.


22. The method of any one of clauses 1 to 19 wherein the effective amount is an amount greater than about 1.0×103 CFU/liter of the wastewater.


23. The method of any one of clauses 1 to 22 further comprising contacting the wastewater with an enzyme selected from the group consisting of a galactosidase, a protease, a lipase, an amylase, a hemicellulase, an arabinoxylanase, a xylanase, a cellulase, an NSPase, a phytase, and combinations thereof.


24. A method of controlling a detrimental effect of wastewater, the method comprising contacting the wastewater with an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and controlling the detrimental effect of the wastewater.


25. The method of clause 24 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.


26. The method of clause 24 or 25 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, wastewater from the manufacture of oil or gas, plant wastewater, and wastewater from the manufacture of food.


27. The method of any one of clauses 24 to 26 wherein the detrimental effect of the wastewater is caused by a pollutant selected from the group consisting of a harmful microorganism, an organic compound, an inorganic compound, and combinations thereof.


28. The method of clause 27 wherein the pollutant is a harmful microorganism and the microorganism is killed.


29. The method of any one of clauses 24 to 28 wherein at least one of the Bacillus strains has antimicrobial activity.


30. The method of clause 29 wherein the antimicrobial activity is against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof.


31. The method of clause 27 wherein the pollutant is an organic compound.


32. The method of clause 31 wherein the organic compound is removed by degradation.


33. The method of clause 31 wherein the organic compound is selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste.


34. The method of clause 27 wherein the pollutant is an inorganic compound.


35. The method of clause 35 wherein the inorganic compound is nitrogen or sulfur.


36. The method of any one of clauses 24 to 35 wherein the Bacillus strain produces an enzyme selected from the group consisting of an a protease, an amylase, a xylanase, a cellulase, and combinations thereof.


37. The method of clause 36 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.


38. The method of any one of clauses 24 to 37 further comprising contacting the wastewater with another bacterial strain selected from the group consisting of another Bacillus strain, a lactic acid bacterial strain, and combinations thereof.


39. The method of any one of clauses 24 to 38 wherein the strain is Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134).


40. The method of any one of clauses 24 to 38 wherein the strain is Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135).


41. The method of any one of clauses 24 to 38 wherein the wastewater is contacted with a composition comprising Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in a single composition.


42. The method of any one of clauses 24 to 38 wherein the wastewater is contacted with Bacillus strain ALG (NRRL No. B-67134), or a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), and Bacillus strain DRT (NRRL No. B-67135), or a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), in combination in separate compositions.


43. The method of any one of clauses 24 to 42 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 5.0×1012 CFU/liter of the wastewater.


44. The method of any one of clauses 24 to 42 wherein the effective amount of the Bacillus strain is about 1.0×103 CFU/liter of the wastewater to about 1.0×1010 CFU/liter of the wastewater.


45. The method of any one of clauses 24 to 42 wherein the effective amount is an amount greater than about 1.0×103 CFU/liter of the wastewater.


46. The method of any one of clauses 24 to 45 further comprising contacting the wastewater with an enzyme selected from the group consisting of a galactosidase, a protease, a lipase, an amylase, a hemicellulase, an arabinoxylanase, a xylanase, a cellulase, an NSPase, a phytase, and combinations thereof.


47. A commercial package comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


48. An additive for wastewater comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


49. A composition comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


50. The commercial package, additive, or composition of any one of clauses 47 to 49 wherein the Bacillus strain causes degradation of an organic compound or removal of an inorganic compound in wastewater.


51. The commercial package, additive, or composition of any one of clauses 47 to 50 wherein the Bacillus strain inhibits a pathogen selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Campylobacter, and Clostridium.


52. The commercial package, additive, or composition of any one of clauses 47 to 51 wherein the Bacillus strain is in the form of a concentrate.


53. The commercial package, additive, or composition of any one of clauses 47 to 51 wherein the Bacillus strain is in the form of a superconcentrate.


54. The commercial package, additive, or composition of any one of clauses 47 to 53 wherein the Bacillus strain is in dry form.


55. The commercial package, additive, or composition of any one of clauses 47 to 54 wherein the Bacillus strain is in pelleted form.


56. The commercial package, additive, or composition of any one of clauses 47 to 55 wherein the Bacillus strain is in a form for use in treatment of wastewater selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, wastewater from the manufacture of oil or gas, plant wastewater, and wastewater from the manufacture of food.


57. The commercial package, additive, or composition of any one of clauses 47 to 56 wherein the strain is in a form selected from the group consisting of a powder, a liquid, and a pellet form.


58. The commercial package, additive, or composition of any one of clauses 47 to 57 further comprising a carrier for the Bacillus strain.


59. The commercial package, additive, or composition of clause 58 wherein the carrier is selected from the group consisting of salt, a dextrin, and combinations thereof.


60. The commercial package, additive, or composition of any one of clauses 47 to 59 in a bag.


61. The commercial package, additive, or composition of clause 60 wherein the bag is a plastic bag.


62. The commercial package, additive, or composition of any one of clauses 47 to 61 further comprising instructions for use of one or more of the Bacillus strains.


63. The commercial package, additive, or composition of any one of clauses 47 to 62 in a 20-pound bag.


64. The commercial package, additive, or composition of any one of clauses 47 to 62 in a 50-pound bag.


65. The commercial package, additive, or composition of any one of clauses 47 to 54 or 56 to 64 wherein the Bacillus strain is in powder form.


66. The commercial package, additive, or composition of any one of clauses 47 to 53 or 56 to 62 wherein the Bacillus strain is in liquid form.


67. The commercial package, additive, or composition of any one of clauses 47 to 66 wherein the Bacillus strain is in a container for commercial use.


68. The commercial package, additive, or composition of clause 67 wherein the container comprises plastic.


69. The commercial package, additive, or composition of clause 67 wherein the container comprises paper.


70. The commercial package, additive, or composition of any one of clauses 47 to 69 further comprising a binder.


71. The commercial package, additive, or composition of clause 70 wherein the binder is selected from the group consisting of clay, yeast cell wall components, aluminum silicate, and glucan, or combinations thereof.


72. The method, commercial package, additive, or composition of any one of clauses 1 to 71 wherein the Bacillus strain retains activity at a temperature as low as 4° C.


In various embodiments, the Bacillus strain (e.g., Bacillus strain ALG and/or DRT) for use in accordance with the methods, commercial packages, additives for wastewater, and compositions described herein can be selected from the group consisting of Bacillus strain ALG, a strain having all of the identifying characteristics of Bacillus strain ALG, Bacillus strain DRT, and a strain having all of the identifying characteristics of Bacillus strain DRT. Bacillus strain MDG ATC 2 and Bacillus strain MDG DRC 2001 were deposited on Sep. 16, 2015 at the Agricultural Research Service Culture Collection (NRRL), International Depository Authority, 1815 North University Street, Peoria, Illinois 61604-3999, and were given accession numbers NRRL B-67134 and NRRL B-67135, respectively. The deposits were made under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. The NRRL strain designations are MDG ATC 2 and MDG DRC 2001, which are equivalent to Bacillus strain ALG and DRT, respectively, as referred to in the application.


Any of these strains can be used to treat wastewater alone or in combination in the form of an additive for wastewater or a composition as described herein (e.g., an additive or a composition further comprising a carrier and/or a binder). In one embodiment, multiple strains are used to treat wastewater in combination in a single composition. In another embodiment, multiple strains are used to treat wastewater in combination in separate compositions.


As used herein “a strain having all of the identifying characteristics of” Bacillus strain ALG or Bacillus strain DRT can be a mutant strain having all of the identifying characteristics of Bacillus strain ALG or Bacillus strain DRT (e.g., a DNA fingerprint based on DNA analysis that corresponds to the DNA fingerprint of Bacillus strain ALG or Bacillus strain DRT, enzyme activities that correspond to Bacillus strain ALG or Bacillus strain DRT, antimicrobial activity that corresponds to Bacillus strain ALG or Bacillus strain DRT, antibiotic sensitivity and tolerance profiles that correspond to Bacillus strain ALG or Bacillus strain DRG, or combinations thereof). In alternate embodiments, the mutation can be a natural mutation, or a genetically engineered mutation. In another embodiment, “a strain having all of the identifying characteristics of” Bacillus strain ALG or Bacillus strain DRT can be a strain, for example, produced by isolating one or more plasmids from Bacillus strain ALG or Bacillus strain DRT and introducing the one or more plasmids into another bacterium, such as another Bacillus strain, as long as the one or more plasmids contain DNA that provides the identifying characteristics of Bacillus strain ALG or Bacillus strain DRT (e.g., a DNA fingerprint based on DNA analysis that corresponds to the DNA fingerprint of Bacillus strain ALG or Bacillus strain DRT).


In one aspect, the microbial strains described herein can show high biological activities (e.g., about 65% to about 100% activity, about 70% to about 100% activity, about 75% to about 100% activity, or about 80% to about 100% activity) even in low temperature environments. In the method, commercial package, additive, or composition embodiments described herein, the Bacillus strain (e.g., ALG and/or DRT) can retain activity (e.g., growth, antibacterial activity, ability to produce enzymes, etc.) at a temperature as low as −30° C., −20° C., −10° C., −5° C., −3° C., −1° C., 0° C., 1° C., 4° C., 8° C., 10° C., 12° C., 15° C., 20° C., or 30° C.


In another embodiment, one or more of the Bacillus strains described in the preceding paragraphs (e.g., Bacillus strain ALG and/or Bacillus strain DRT) can be used to treat wastewater along with another bacterial strain selected from the group consisting of another Bacillus strain, a lactic acid bacterial strain, and combinations thereof. In yet another embodiment, one or more of the Bacillus strains described in the preceding paragraphs (e.g., Bacillus strain ALG and/or Bacillus strain DRT) can be used to treat wastewater along with any other bacterial strain effective to treat wastewater to remove pollutants or to control detrimental effects of wastewater.


The additive for wastewater or the composition described herein can be used to treat wastewater for any period of time that is effective to remove pollutants and/or control the detrimental effects of wastewater. For example, in one embodiment treatment of wastewater can occur daily. The time periods for treatment of wastewater are non-limiting and it should be appreciated that any time period or treatment schedule determined to be effective to remove pollutants and/or control the detrimental effects of wastewater may be used.


In various illustrative embodiments, the Bacillus strain (e.g., Bacillus strain ALG and/or DRT), or any other bacterial strains added in addition to Bacillus strain ALG and/or DRT, can be added to the wastewater at about 1.0×103 CFU/liter of the wastewater to about 5.0×1012 CFU/liter of the wastewater or at about 1.0×103 CFU/liter of the wastewater to about 1.0×1010 CFU/liter of the wastewater. In other embodiments, the Bacillus strain (e.g., Bacillus strain ALG and/or DRT) can be added to the wastewater at an amount greater than about 1.0×103 CFU/liter of the wastewater, at greater than about 1.1×103 CFU/liter of the wastewater, at greater than about 1.25×103 CFU/ liter of the wastewater, at greater than about 1.5×103 CFU/ liter of the wastewater, at greater than about 1.75×103 CFU/liter of the wastewater, at greater than about 1.0×104 CFU/liter of the wastewater, at greater than about 2.0×104 CFU/liter of the wastewater, at greater than about 3.0×104 CFU/liter of the wastewater, at greater than about 4.0×104 CFU/liter of the wastewater, at greater than about 5.0×104 CFU/liter of the wastewater, at greater than about 6.0×104 CFU/liter of the wastewater, at greater than about 7.0×104 CFU/liter of the wastewater, at greater than about 8.0×104 CFU/liter of the wastewater, at greater than about 1.0×105 CFU/liter of the wastewater, at greater than about 1.0×106 CFU/liter of the wastewater, at greater than about 1.0×107 CFU/liter of the wastewater, at greater than about 1.0×108 CFU/liter of the wastewater, at greater than about 1.0×109 CFU/liter of the wastewater, at greater than about 1.0×1010 CFU/liter of the wastewater, at greater than about 1.0×1011 CFU/liter of the wastewater, or at greater than about 1.0×1012 CFU/liter of the wastewater.


In various embodiments, the wastewater described herein can be selected from the group consisting of industrial wastewater and sewage wastewater. In these embodiments, the wastewater can be selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from the manufacture of a pharmaceutical, wastewater from the manufacture of a pesticide, wastewater from the manufacture of paper, wastewater from the manufacture of oil or gas, and wastewater from the manufacture of food, or any other type of wastewater comprising pollutants that need to be removed or having a detrimental effect that needs to be controlled.


As used herein “remove a pollutant” or “removal of a pollutant” means completely removing the pollutant, reducing the amount of the pollutant, inactivating the pollutant, degrading the pollutant, or causing the pollutant to be converted to an inactivated form. In the case of a harmful microorganism “remove a pollutant” or “removal of a pollutant” can also mean killing the microorganism, reducing the number of the harmful microorganisms in the wastewater, and/or inhibiting the activity of the microorganism.


In various illustrative aspects, the pollutants that can be removed from the wastewater can be selected from the group consisting of a harmful microorganism, an organic compound, an inorganic compound, and combinations thereof. In some embodiments described herein, at least one of the Bacillus strains can have antimicrobial activity. Such antimicrobial activity can be against, for example, E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof.


In the embodiment where the pollutant is an organic compound, the organic compound can be removed by degradation. In this embodiment, the organic compound can be selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste, or any other organic compound that is a pollutant in wastewater or is the cause of a detrimental effect of wastewater. In the embodiment where the pollutant is an inorganic compound, the inorganic compound can be, for example, nitrogen or sulfur.


In various illustrative aspects, the Bacillus strains described herein (i.e., Bacillus strains ALG and/or DRT) produce an enzyme selected from the group consisting of a protease, an amylase, a xylanase, a cellulase, and combinations thereof. In the embodiment wherein the enzyme is a cellulase, the cellulase can be a carboxymethylcellulase.


In one illustrative embodiment, one or more enzymes may be added to the additive for wastewater or the composition described herein or may be added directly to the wastewater in combination with the Bacillus strains described herein. In various embodiments, the enzymes that may be used to treat the wastewater in addition to the Bacillus strains include a galactosidase, a phytase, a protease, a lipase, an amylase, a hemicellulase, an arabinoxylanase, a xylanase, a cellulase, an NSPase, combinations thereof, and any other enzyme that is suitable to treat wastewater to remove pollutants or control a detrimental effect of wastewater. Any of the enzymes described above that are suitable for treatment of wastewater may be added as a component of the commercial package, additive for wastewater, or composition described herein, or may be added directly the wastewater as a separate composition.


In additional embodiments of the invention, compositions comprising Bacillus strain ALG and/or Bacillus strain DRT are provided. In one embodiment, a commercial package is provided comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


In another embodiment, an additive for wastewater is provided comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


In yet another embodiment, a composition is provided comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), a strain having all of the identifying characteristics of Bacillus strain ALG (NRRL No. B-67134), a strain having all of the identifying characteristics of Bacillus strain DRT (NRRL No. B-67135), and combinations thereof.


In these embodiments the Bacillus strain can be in the form of, for example, a powder, a liquid, or pellets, and can be mixed with the wastewater using any suitable method known in the art to achieve any of the amounts of Bacillus strain ALG and Bacillus strain DRT described herein, for the treatment of wastewater to remove pollutants or to control a detrimental effect of wastewater.


In any of the composition embodiments described herein, the Bacillus strain ALG and/or Bacillus strain DRT can inhibit a pathogen selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof. These types of microorganisms are non-limiting examples of the types of microorganisms Bacillus strain ALG and/or Bacillus strain DRT can inhibit. In these embodiments, the Bacillus strain (e.g., ALG and/or DRT) can cause degradation of an organic compound or removal of an inorganic compound in wastewater.


In illustrative aspects, the Bacillus strain ALG and/or Bacillus strain DRT can be in the form of a commercial package, an additive for wastewater or any suitable composition. In another illustrative embodiment, the Bacillus strain ALG and/or Bacillus strain DRT in the commercial package, additive for wastewater, or composition can be in the form of a concentrate (e.g., about 1×108 to about 5×109 CFU/g) or a superconcentrate (e.g., about 1×1010 to about 5×1012 CFU/g). In another embodiment, the Bacillus strain ALG and/or Bacillus strain DRT in the commercial package, additive for wastewater, or composition can be in a dry form (e.g., a powder), a pelleted form, a liquid form, a freeze-dried form, or in the form of a gel, or any other suitable form.


In another illustrative embodiment, the Bacillus strain in the commercial package, additive for wastewater, or composition can further comprise a carrier for the Bacillus strain ALG and/or Bacillus strain DRT. The carrier can be selected from the group consisting of a salt, mineral oil, a dextrin (e.g., maltodextrin), whey, sugar, limestone, dried starch, sodium silico aluminate, and combinations thereof. In another embodiment, the carrier can be any suitable carrier known in the art for a composition for treating wastewater. In another embodiment, the Bacillus strain in the commercial package, additive for wastewater, or composition can further comprise a binder such as clay, yeast cell wall components, aluminum silicate, glucan, or other known binders, and/or micronutrients.


In yet other embodiments, the commercial package, additive for wastewater, or composition comprising Bacillus strain ALG and/or Bacillus strain DRT is in a container for commercial use. In various embodiments the container can be, for example, a bag (e.g., a 20-pound bag, a 50-pound bag, a 2-ounce bag, a 1-pound bag, or a 1-kilogram bag), a pouch, a drum, a bottle, or a box. In illustrative aspects, the container comprising Bacillus strain ALG and/or Bacillus strain DRT can comprise plastic, metal, foil, paper, fiber, or cardboard (e.g., a plastic pail, a paper bag, a foil bag, a fiber drum, etc.). The commercial package can further comprise instructions for use of one or more of the Bacillus strains.


The following examples are for illustrative purposes only. The examples are non-limiting, and are not intended to limit the invention in any way.


EXAMPLE 1
Biological Growth Activity of Microbial Strains at Different Temperatures

The objective of the instant example was to compare the growth ability of microbial strains of the present disclosure at different temperature ranges. Two different microbial strains of the present disclosure (i.e., ALG (ACT 2) and DRT (DRC 2001)) were tested for their growth at different temperatures when grown in tryptic soy broth. Samples of each microbial strain were taken after 72 hours of incubation at 4° C., 15° C., 20° C., and 32° C. The microbial samples were then tested for biological growth activity as assessed by optical density using a spectrometer.


As shown in Table 1, both of the microbial strains of the present disclosure showed biological growth activities at the different temperatures tested. For example, the ACT 2 (ALG) microbial strain showed a similar O.D. of 1.001 and 1.000 at the low temperature, 4° C., and the high temperature, 32° C., respectively. However, the growth activity of the ACT 2 (ALG) strain was similar at 15° C. and 20° C. with O.D.s of 1.456 and 1.463, respectively.


Similarly, the DRC 2001 (DRT) microbial strain showed a similar O.D. of 1.060 and 1.012 at the low temperature, 4° C., and the high temperature, 32° C., respectively (see Table 1). However, the growth activity of the DRC 2001 (DRT) microbial strain at 15° C. and 20° C. had an O.D. of 1.477 and 1.488, respectively.















TABLE 1







Temperature
4° C.
15° C.
20° C.
32° C.









ACT 2 (O.D.)
1.001
1.456
1.463
1.000



DRC 2001 (O.D.)
1.060
1.477
1.488
1.012










EXAMPLE 2
Biological Activity of Microbial Strains in Different Wastewater Types and at Different Temperatures

The objective of the instant example was to compare the biological activities of the microbial strains of the present disclosure using different wastewater samples at different temperatures. For example, industrial wastewater at 4° C. (see FIG. 1A) and 20° C. (see FIG. 1A) was treated with ACT 2 (ALG) and DRC 2001 (DRT) microbial strains independently, or with a combination of ACT 2 (ALG) and DRC 2001 (DRT) microbial strains, and a control sample.


As shown in FIGS. 1A and 1B, the combination of the ACT 2 (ALG) and DRC 2001 (DRT) microbial strains had greater biological activity than either the ACT 2 or the DRC 2001 microbial strains independently in industrial wastewater at 4° C. and 20° C. However, both the ACT 2 and DRC 2001 microbial strains independently had greater biological activity than the control microbe in industrial wastewater at 4° C. and 20° C. (see FIGS. 1A and 1B).


Similar results are shown for dairy pond industrial wastewater in FIGS. 1C and 1D. Each sample was adjusted to optimal conditions following the ratio of BOD:NH4:PO4 of 100:5:1 and each sample was run at 4° C. and 20° C. using a BODtrak Respirometric BOD apparatus from Hach.


EXAMPLE 3
Enzyme Activity of Microbial Strain Composites at Different Temperatures

The objective of the instant example was to ascertain the enzyme activities of the microbial composites of the present disclosure at different temperatures. Enzyme assay media plates were prepared by supplementing tryptic soy agar with between 0.5% and 1% of various substrates, including polysaccharides (e.g., corn starch, carboxymethylcellulose, or xylan) or proteins (e.g., casein). Five microliters (5 μL) of Bacillus microbial strains of the present disclosure, ALG and DRT, were obtained from fresh overnight cultures, and were spotted onto agar plates. The inoculated agar plates were incubated at various temperatures, such as 4° C., 15° C., 20° C., and 32° C. for a time period ranging from about 4 to about 48 hours. Zones of clearing around enzyme-producing colonies were visible on protein agar plates without further treatment. Polysaccharide-containing agar plates were stained with Gram's iodine for 1 minute to visualize zones of clearing.


As shown in Table 2, both ALG and DRT microbial strains were observed to be positive for protease, amylase, carboxymethylcellulose (i.e., CMCase), and xylanase activity after 48 hours at 4° C. ALG and DRT microbial strains were also observed to have positive enzyme activity for three tested enzymes (zylanase, protease, and CMCase) after 48 hours at 15° C., 25° C., and 32° C. (see Table 2). In contrast, neither ALG nor DRT microbial strains were observed to have positive amylase activity after 48 hours at 15° C., 25° C., and 32° C. (see Table 2).














TABLE 2





Temperature
Strain
Xylanase
CMCase
Amylase
Protease







 4° C.
ALG
+
+
+
+



DRT
+
+
+
+


15° C.
ALG
+
+
−
+



DRT
+
+
−
+


25° C.
ALG
+
+
−
+



DRT
+
+
−
+


32° C.
ALG
+
+
−
+



DRT
+
+
−
+









EXAMPLE 4
Genomic Analysis of Microbial Strains ALG and DRT

In order to obtain genomic “fingerprints” of Bacillus strains ALG and DRT collected in the strain library, Next Generation Sequencing analysis was performed according to the manufacturer's instructions with each Bacillus strain. The raw sequencing data was assembled de novo into contigs and consensus sequences. Gene prediction using the microbial genome was then followed by functional annotation of novel sequences.



FIGS. 2 and 3 show genomic annotation of microbial strains ALG and DRT, respectively. As shown in FIG. 2, microbial strain ALG comprises approximately 3,929,138 bp (i.e., about 3929 kb) of genomic sequence. Microbial strain DRT was slightly smaller comprising about 3,654,632 bp (i.e., about 3654 kb) of genomic sequence. Therefore, FIGS. 2 and 3 demonstrate that microbial strains ALG and DRT are different strains, each having a unique DNA fingerprint. In addition, sequencing of Microbial strains ALG and DRT identified many different genes within the strains.

Claims
  • 1. A method of treating wastewater by contacting the wastewater with a Bacillus strain to remove a microorganism, the method comprising contacting the wastewater with an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the microorganism wherein the microorganism is removed by killing the microorganism and wherein at least one of the Bacillus strains has antimicrobial activity against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof, wherein the Bacillus strains maintain growth activity at a temperature of 4° C. relative to the growth activity of the strains at 32° C.
  • 2. The method of claim 1 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.
  • 3. The method of claim 1 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from manufacturing a pharmaceutical, wastewater from manufacturing a pesticide, wastewater from manufacturing paper, wastewater from manufacturing oil or gas, plant wastewater, and wastewater from manufacturing food.
  • 4. The method of claim 1 wherein the Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, produces an enzyme selected from the group consisting of a protease, an amylase, a xylanase, a cellulase, and combinations thereof.
  • 5. The method of claim 4 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.
  • 6. The method of claim 1 wherein the wastewater is further treated with a Bacillus strain different from Bacillus strain ALG (NRRL No. B-67134) or different from Bacillus strain DRT (NRRL No. B-67135), or a lactic acid bacterial strain, and combinations of the different strains and the lactic acid bacterial strain that are used for further treatment.
  • 7. The method of claim 1 wherein Bacillus strain ALG (NRRL No. B-67134) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 8. The method of claim 1 wherein Bacillus strain DRT (NRRL No. B-67135) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 9. The method of claim 1 wherein the wastewater is treated with a composition comprising Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in combination in a single treatment.
  • 10. The method of claim 1 wherein the wastewater is treated with Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in separate treatments.
  • 11. The method of claim 1 wherein the amount of the Bacillus strain is about 1.0×103 colony-forming units/liter of the wastewater to about 5.0×1012 colony-forming units/liter of the wastewater.
  • 12. The method of claim 1 wherein the wastewater is contacted with a mixture of Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135), wherein each of said Bacillus strains produces a carboxymethylcellulase.
  • 13. A method of treating wastewater by contacting the wastewater with a Bacillus strain to remove an organic compound, the method comprising contacting the wastewater with an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the organic compound wherein the organic compound is removed by degradation and wherein at least one of the Bacillus strains has antimicrobial activity against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof, wherein the Bacillus strains maintain growth activity at a temperature of 4° C. relative to the growth activity of the strains at 32° C.
  • 14. The method of claim 13 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.
  • 15. The method of claim 13 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from manufacturing a pharmaceutical, wastewater from manufacturing a pesticide, wastewater from manufacturing paper, wastewater from manufacturing oil or gas, plant wastewater, and wastewater from manufacturing food.
  • 16. The method of claim 13 wherein the organic compound is selected from the group consisting of a pharmaceutical, a pesticide, a by-product of a tannery process, a by-product of paper manufacture, a by-product of pesticide manufacture, a by-product of oil or gas manufacture, a by-product of food manufacture, and a by-product of human waste.
  • 17. The method of claim 13 wherein the Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, produces an enzyme selected from the group consisting of a protease, an amylase, a xylanase, a cellulase, and combinations thereof.
  • 18. The method of claim 17 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.
  • 19. The method of claim 13 wherein the wastewater is further treated with a Bacillus strain different from Bacillus strain ALG (NRRL No. B-67134) or different from Bacillus strain DRT (NRRL No. B-67135), or a lactic acid bacterial strain, and combinations of the different strains and the lactic acid bacterial strain that are used for further treatment.
  • 20. The method of claim 13 wherein Bacillus strain ALG (NRRL No. B-67134) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 21. The method of claim 13 wherein Bacillus strain DRT (NRRL No. B-67135) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 22. The method of claim 13 wherein the wastewater is treated with a composition comprising Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in combination in a single treatment.
  • 23. The method of claim 13 wherein the wastewater is treated with Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in separate treatments.
  • 24. The method of claim 13 wherein the amount of the Bacillus strain is about 1.0×103 colony-forming units/liter of the wastewater to about 5.0×1012 colony-forming units/liter of the wastewater.
  • 25. A method of treating wastewater by contacting the wastewater with a Bacillus strain to remove an inorganic compound, the method comprising contacting the wastewater with an isolated Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, and removing the inorganic compound by reducing the amount of the inorganic compound and wherein at least one of the Bacillus strains has antimicrobial activity against bacteria selected from the group consisting of E. coli, Salmonella, Staphylococcus, Enterococcus, Clostridia, Campylobacter, and combinations thereof, wherein the Bacillus strains maintain growth activity at a temperature of 4° C. relative to the growth activity of the strains at 32° C.
  • 26. The method of claim 25 wherein the wastewater is selected from the group consisting of industrial wastewater and sewage wastewater.
  • 27. The method of claim 25 wherein the wastewater is selected from the group consisting of dairy pond wastewater, grease trap wastewater, sewage wastewater, industrial cooling water wastewater, tannery wastewater, wastewater from manufacturing a pharmaceutical, wastewater from manufacturing a pesticide, wastewater from manufacturing paper, wastewater from manufacturing oil or gas, plant wastewater, and wastewater from manufacturing food.
  • 28. The method of claim 25 wherein the inorganic compound is nitrogen or sulfur.
  • 29. The method of claim 25 wherein the Bacillus strain selected from the group consisting of Bacillus strain ALG (NRRL No. B-67134), Bacillus strain DRT (NRRL No. B-67135), and combinations thereof, produces an enzyme selected from the group consisting of a protease, an amylase, a xylanase, a cellulase, and combinations thereof.
  • 30. The method of claim 29 wherein the enzyme is a cellulase and the cellulase is a carboxymethylcellulase.
  • 31. The method of claim 25 wherein the wastewater is further treated with a Bacillus strain different from Bacillus strain ALG (NRRL No. B-67134) or different from Bacillus strain DRT (NRRL No. B-67135), or a lactic acid bacterial strain, and combinations of the different strains and the lactic acid bacterial strain that are used for further treatment.
  • 32. The method of claim 25 wherein Bacillus strain ALG (NRRL No. B-67134) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 33. The method of claim 25 wherein Bacillus strain DRT (NRRL No. B-67135) is selected as a sole Bacillus strain placed in contact with said wastewater.
  • 34. The method of claim 25 wherein the wastewater is treated with a composition comprising Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in combination in a single treatment.
  • 35. The method of claim 25 wherein the wastewater is treated with Bacillus strain ALG (NRRL No. B-67134) and Bacillus strain DRT (NRRL No. B-67135) in separate treatments.
  • 36. The method of claim 25 wherein the amount of the Bacillus strain is about 1.0×103 colony-forming units/liter of the wastewater to about 5.0×1012 colony-forming units/liter of the wastewater.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 62/265,295 filed Dec. 9, 2015 the disclosure of which are hereby expressly incorporated by reference in its entirety, respectively.

US Referenced Citations (53)
Number Name Date Kind
4673638 Grosch et al. Jun 1987 A
5587475 Helquist et al. Dec 1996 A
5589381 Neyra et al. Dec 1996 A
5665354 Neyra Sep 1997 A
6268147 Beattie Jul 2001 B1
7754469 Baltzley et al. Jul 2010 B2
7807185 Farmer Oct 2010 B2
8025874 Bellot et al. Sep 2011 B2
8540981 Wehnes et al. Sep 2013 B1
9175258 Bywater-Ekegard Nov 2015 B2
9410213 Matheny Aug 2016 B2
9758414 Dash et al. Sep 2017 B2
10961275 Bralkowski et al. Mar 2021 B2
20010027947 Tsuchiya Oct 2001 A1
20050255092 Rehberger et al. Nov 2005 A1
20050266468 Bedzyk Dec 2005 A1
20060188978 Grant Aug 2006 A1
20080050774 Berka Feb 2008 A1
20090280090 Rehberger et al. Nov 2009 A1
20100010080 Mockett et al. Jan 2010 A1
20100062021 Winkelman Mar 2010 A1
20100092428 Schmidt et al. Apr 2010 A1
20100291564 Stanley Nov 2010 A1
20120100118 Rehberger et al. Apr 2012 A1
20120015259 Friedlander et al. Dec 2012 A1
20120315258 Rehberger et al. Dec 2012 A1
20120315259 Friedlander et al. Dec 2012 A1
20130064927 Davis et al. Mar 2013 A1
20130098837 Dash Apr 2013 A1
20130100118 Mlyniec et al. Apr 2013 A1
20130136695 Hargis et al. May 2013 A1
20130216586 LeBrun et al. Aug 2013 A1
20130295067 Baltzley et al. Nov 2013 A1
20140106974 Sun et al. Apr 2014 A1
20140141044 Dana-Farber May 2014 A1
20140273150 Angel Sep 2014 A1
20140315716 Matheny Oct 2014 A1
20140363819 Rowlyk Dec 2014 A1
20150079058 Nielsen et al. Mar 2015 A1
20150111214 Liu Apr 2015 A1
20150147303 Hsieh May 2015 A1
20150216203 Dupont Aug 2015 A1
20150216916 Dupont Aug 2015 A1
20160108467 Semikhodskii et al. Apr 2016 A1
20170079308 King et al. Mar 2017 A1
20170166466 King et al. Jun 2017 A1
20170246224 King et al. Aug 2017 A1
20170327840 Bayer Nov 2017 A1
20180361444 Franssen Dec 2018 A1
20190021341 Church et al. Jan 2019 A1
20200015497 King et al. Jan 2020 A1
20200029592 King et al. Jan 2020 A1
20200093158 Calabotta et al. Mar 2020 A1
Foreign Referenced Citations (34)
Number Date Country
2948832 Nov 2015 CA
101159102 Apr 2008 CN
102223809 Oct 2011 CN
103980535 Aug 2014 CN
107841478 Mar 2018 CN
109497281 Mar 2019 CN
1574564 Sep 2005 EP
1392813 Apr 1975 GB
1434582 May 1976 GB
3417904 Jun 2003 JP
100427600 Apr 2004 KR
2007083147 Jul 2007 WO
2010032233 Mar 2010 WO
2010033714 Mar 2010 WO
2012009712 Jan 2012 WO
2012101528 Aug 2012 WO
2014020141 Feb 2014 WO
2014067081 May 2014 WO
20140172520 Oct 2014 WO
2015057330 Apr 2015 WO
2015160960 Oct 2015 WO
2015175667 Nov 2015 WO
2017081105 May 2017 WO
2017151608 Sep 2017 WO
2018148847 Aug 2018 WO
2019090068 May 2019 WO
2019090088 May 2019 WO
2019141815 Jul 2019 WO
2019152791 Aug 2019 WO
2019213243 Nov 2019 WO
2020072578 Apr 2020 WO
2021035137 Feb 2021 WO
2021041603 Mar 2021 WO
2023018686 Feb 2023 WO
Non-Patent Literature Citations (57)
Entry
Sumi et al., Antimicrobial peptides of the genus Bacillus: a new era for antibiotics, Nov. 19, 2014, p. 1-7 (Year: 2014).
EPA, Final Risk Assessment of Bacillus Subtilis, Feb. 1997, p. 3, 9 (Year: 1997).
Karigar et al., “Role of Microbial Enzymes in the Bioremediation of Pollutants: A Review,” Enzyme Research, vol. 2011, Article ID 805187, 11 pages.
Schmidt et al., “New Concepts of microbial treatment processes for the nitrogen removal in wastewater,” 2003.
Ramachandran et al., “A Broad-Spectrum Antimicrobial Activity of Bacillus subtilis RLID 12.1,” 2014.
Kiarie et al. “The Role of Added Feed Enzymes in Promoting Gut Health in Swine and Poultry,” Nutrition Research Reviews, Jun. 1, 2013 (Jun. 1, 2013), vol. 26, pp. 71-88. Entire document.
La Ragione et al. “Bacillus subtilis Spores Competitively Exclude Escherichia coli O78: K80 in Poultry,” Veterinary Microbiology, Mar. 20, 2001 (Mar. 20, 2001). vol. 79, pp. 133-142. Entire document.
Harnentis et al. “Isolation, Characterization and Production of Mannanase from Thermophilic Bacteria to Increase the Feed Quality,” Pakistan Journal of Nutrition 12 (4): 360-364, 2013.
PCT Search Report and Written Opinion for PCT/US2015/030578, completed Jul. 9, 2015.
Extended European Search Report, European Application No. 15792802.9-1358 dated Nov. 8, 2017, 8 pages.
Souza et al. J. Anim. Sci. vol. 90, Suppl. 3/J. Dairy Sci. vol. 95, Suppl. 2 T281.
Credille et al. (2014). Prevalence of bacteremia in dairy cattle with acute puerperal metritis. J Vet Intern Med, 28:1606-1612.
Sheldon et al. (2009). Defining postpartum uterine disease and the mechanisms of infection and immunity in the female reproductive tract in cattle. Biol Reprod 81:1025-1032.
Abutarbush et al. (2005). Jejunal hemorrhage syndrome in dairy and beef cattle: 11 cases (2001 to 2003). Can. Vet. J. Rev. Vét. Can. 46, 711-715.
Abutarbush et al. (2004). Jejunal hemorrhage syndrome in 2 Canadian beef cows. Can. Vet. J. 45, 48-50.
Adaska et al. (2014). Jejunal hematoma in cattle: a retrospective case analysis. J. Vet. Diagn. Investig. Off. Publ. Am. Assoc. Vet. Lab. Diagn. Inc 26, 96-103.
Baines et al. (2011). Mouldy feed, mycotoxins and Shiga toxin—producing Escherichia coli colonization associated with Jejunal Hemorrhage Syndrome in beef cattle. BMC Vet. Res. 7, 24.
Ceci, L., Paradies, P., Sasanelli, M., De Caprariis, D., Guarda, F., Capucchio, M. t., and Carelli, G. (2006). Haemorrhagic Bowel Syndrome in Dairy Cattle: Possible Role of Clostridium perfringens Type A in the Disease Complex. J. Vet. Med. Ser. A 53, 518-523.
Dennison et al. (2002). Hemorrhagic bowel syndrome in dairy cattle: 22 cases (1997-2000). J. Am. Vet. Med. Assoc. 221, 686-689.
Dennison et al. (2005). Comparison of the odds of isolation, genotypes, and in vivo production of major toxins by Clostridium perfringens obtained from the gastrointestinal tract of dairy cows with hemorrhagic bowel syndrome or left-displaced abomasum. J. Am. Vet. Med. Assoc. 227, 132-138.
Malinen et al. (2003). Comparison of real-time PCR with SYBR Green I or 5 ′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology. 149: 269-277.
West et al. (2007) Rapid Detection of Escherichia coli Virulence Factor Genes using Multiplex Real-Time TaqMan®PCR Assays. Veterinary Microbiology 122(3-4): 323-331.
Frydendahl et al. (2001). Automated 5′ nuclease assay for detection of virulence factors in porcine Escherichia coli. Molec.Cell, Probes. 15: 151-160.
Nielsen et al. (2003). Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5 nuclease PCR assay, Journal of ClinicalMicrobiology, vol. 41, No. 7, pp. 2884-2893.
Jinneman et al. (2003). Multiplex Real-Time PCR Method To Identify Shiga Toxin Genes stx1 and stx2 and Escherichia coli O157:H7/H-Serotype. Appl. Environ. Microbiol. Oct. 2003 vol. 69 No. 10 6327-6333.
Yatsuyanagi et al. (2002). Characterization of enteropathogenic and enteroaggregative Escherichia coli isolated from diarrheal outbreaks, Journal of Clinical Microbiology, vol. 40, No. 1, pp. 294-297.
Albini et al. (2010). Real-time multiplex PCR assays for reliable detection of Clostridium perfringens toxin genes in animal isolates, Veterinary Microbiology, 127 (1-2): 179-185.
Johnson et al. (2012). A MIQE-Compliant Real-Time PCR Assay for Aspergillus Detection., PLOSone., 7(7): 1-8.
Miller et al., “Sanitary Landfill Simulation: Test Parameters and a Simulator Conceptual Design,” Naval Facilities Engineering Command: Civil Engineering Laboratory, Oct. 20, 1976 (Oct. 20, 1976), pp. 1-47. Retrieved from the Internet: <https://apps.dtic.mil/dtic/tr/fulltext/u2/a030998.pdf>.
Fei et al., “A laboratory landfill simulator for physical, geotechnical, chemical and microbial characterization of solid waste biodegradation processes,” Couples Phenomena in Environmental Geotechnics, May 20, 2013 (May 30, 2013), Taylor & Francis Group, London, pp. 321-327.
Mahar et al., “Modeling and simulation of landfill gas production from pretreated MSW landfill simulator,” Frontiers of Environmental Science & Engineering, Apr. 15, 2014 (Apr. 15, 2014), vol. 10, Iss. 1, pp. 159-167.
Canning, et al., “Effect of direct-fed microbial Bacillus subtilis C-3102 on enteric health in nursery pigs after challenge with porcine epidemic diarrhea virus,” Journal of Swine Health and Production, May 3, 2017, 25(3): 129-137.
Peng, et al., “Evaluation of antiviral activity of Bacillus licheniformis-fermented products against porcine epidemic diarrhea virus,” AMB Express, Dec. 3, 2019, 9(191): 1-12.
Bae H.D., Yanke L.J, Cheng K.J., Selinger L.B., 1999, “A novel staining method for detecting phytase activity,” Journal of Microbiological Methods, 39:1, 17-22.
Zganjer, et al. “Treatment of rectal prolapse in children with cow milk injection sclerotherapy: 30-year experience,” World Journal of Gastroanterology, 2008, 14(5) 740-7.
Rajendram et al., Journal of Microbiological Methods, 2006, 67, 582-92.
Krishnani, Genbank entry KJ000877 published Feb. 2014.
Lowe, et al., Nucleic Acids Research, 1990, 18(7) 1757-61.
Mcclure et al. “Assessment of DNA extracted from FTA® cards for use on the Illumina iSelect Beach Chip,” BMC Research Notes, 2009, 2(107) 4 pages.
Haldar et al., “Development of a haemolysin gene-based multiplex PCR for simultaneous detection of Vibrio campbelli, Vibrio harveyi and Vibrio parahaemolyticus,” Letters in Applied Microbiology, 2010, 50, 146-52.
EP Search report in EP 16789853 completed Aug. 8, 2018.
International search report and written opinion for PCT/US2017/019941, mailed May 26, 2017.
International search report and written opinion for PCT/US2018/058948, mailed Jan. 18, 2019.
International Search Report prepared for PCT/US2020/048101 mailed Jan. 22, 2021.
International Search Report prepared for PCT/US2020/047390 , mailed Jan. 21, 2021.
Sonune et al. “Isolation, characterization and identification of extracellular enzyme producer Bacillus licheniformis from municipal wastewater and evaluation of the biodegradability,” Biotechnology Research and Innovation, Jan-Dec. 2018, vol. 2, No. 1 pp. 37-44.
Safitri et al. “Ability of Bacterial Consortium: Bacillus coagulans, Bacilus licheniformis, Bacillus pumilus, Bacillus subtilis, Nitrosomonas sp. and Pseudomonas putida in Bioremediation of Waste Water in Cisirung Waste Water Treatment Plant,” AgroLife Scientific Journal, 2015, vol. 4, No. 1, pp. 146-152.
Ou et al. “Identification of HIV-1 infected infants and young children using real-time RT PCR and dried blood spots from Uganda and Cameroon,” Journal of Virological Methods, 2007, 144, 109-14.
Dobbs et al , 2002 Arch Pathol Lab Med. vol. 126, p. 56-63.
Chen et al, 2013 J of Proteome Research, 12, p. 1151-1161.
International search report and written opinion for PCT/US2019/030182, mailed Aug. 8, 2019.
Choudhary et al 2009 (interactions of Bacillus supp. and plants—with special reference to induced systemic resistance (ISR): Microbiologial Research 164: 493-513).
International search report and written opinion for PCT/US2020/023586, mailed May 20, 2020.
European Search Report, European Application No. 20855232.3-1105 dated Aug. 31, 2023, 8 pages.
Supp. European Search Report, European Application No. 20858946, dated Aug. 23, 2023.
Sonune et al., “Isolation, characterization and identification of extracellular enzyme producer Bacillus licheniformis from municipal wastewater and evaluation of their biodegradability.” Biotechnology Research and Innovation, vol. 2, No. 1, Jan. 1, 2018, pp. 37-44.
Cohn et al., “Bacillus Strains Improving Health and Performance of Production Animals.” IP.com, IP.COM Inc., Feb. 11, 2016, p. 36, line 54.
Related Publications (1)
Number Date Country
20170166466 A1 Jun 2017 US
Provisional Applications (1)
Number Date Country
62265295 Dec 2015 US